Postpartum thyroiditis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Postpartum thyroiditis}}
{{Postpartum thyroiditis}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SKA}}


==Overview==
==Overview==
Prognosis is generally good, 25-30% in 3.5 to 8.7-year patients with [[postpartum thyroiditis]] PPT develop [[hypothyroidism]]. The symptoms of postpartum thyroiditis, PPT usually develop in the twelve months after delivery, abortion or miscarriage of fetus and start with symptoms depending on clinical course that it follows. Common complications of include hypothyroidism, postpartum depression, fetal mental retardation in future pregnancies in diagnosed cases and overt hyperthyroid symptoms in future pregnancies.
[[Prognosis]] for postpartum thyroiditis is generally good. If left untreated, 25 to 30% patients develop [[hypothyroidism]], 3.5 to 8.7-years after developing [[postpartum thyroiditis]] [[Postpartum thyroiditis|(PPT)]]. The symptoms of [[postpartum thyroiditis]] usually develop in the twelve months after [[delivery]], [[abortion]] or [[miscarriage]] of fetus. The symptoms of PPT depend on its clinical course such as classic triphasic, biphasic hyerthyroidism, or biphasic hypothyroidism. Common complications of PPT include [[hypothyroidism]], [[Postpartum depression (patient information)|postpartum depression]], and [[Mental retardation|fetal mental retardation]]. The mother may develop overt [[Hyperthyroidism|hyperthyroid]] symptoms in future pregnancies. Prognosis of PPT is generally good and 90% of patient recover to normal state after [[postpartum]] period.


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


===Natural History===
===Natural History===
*The symptoms of [[postpartum thyroiditis]], PPT  usually develop in the twelve months after devilry , [[abortion]] or [[miscarriage]] of [[fetus]] and start with symptoms depending on clinical course that it follows.
*The symptoms of [[postpartum thyroiditis]] (PPT) usually develop in the twelve months after [[delivery]], [[abortion]] or [[miscarriage]] of [[fetus]]. 
*There are three clinical courses:  
*The symptoms of PPT depend on its clinical course such as:  
:*Classic triphasic: 25% of patients of PPT come to clinical attention with symptoms of [[hyperthyroidism]] starting from sixth [[postpartum]] week<ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538  }} </ref> followed by hypothyroidism around sixth postpartum month and then euthyroidisum by the of 12 months of postpartum .<ref name="pmid22312089">{{cite journal| author=Stagnaro-Green A| title=Approach to the patient with postpartum thyroiditis. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 2 | pages= 334-42 | pmid=22312089 | doi=10.1210/jc.2011-2576 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22312089  }} </ref>
:*'''Classic triphasic''': 25% patients of [[Postpartum thyroiditis|PPT]] come to clinical attention with symptoms of [[hyperthyroidism]] starting from sixth [[postpartum]] week followed by hypothyroidism around sixth postpartum month and then euthyroidism by the of 12th postpartum month.<ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538  }} </ref><ref name="pmid22312089">{{cite journal| author=Stagnaro-Green A| title=Approach to the patient with postpartum thyroiditis. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 2 | pages= 334-42 | pmid=22312089 | doi=10.1210/jc.2011-2576 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22312089  }} </ref>
:*Biphasic [[hyperthyroidism]]: 32 % patients of PPT develops symptoms of [[hyperthyroidism]] followed recovery.<ref name="pmid22312089">{{cite journal| author=Stagnaro-Green A| title=Approach to the patient with postpartum thyroiditis. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 2 | pages= 334-42 | pmid=22312089 | doi=10.1210/jc.2011-2576 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22312089  }} </ref>
:*'''Biphasic [[hyperthyroidism]]''': 32 % patients of PPT develop symptoms of [[hyperthyroidism]] followed by recovery.<ref name="pmid22312089">{{cite journal| author=Stagnaro-Green A| title=Approach to the patient with postpartum thyroiditis. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 2 | pages= 334-42 | pmid=22312089 | doi=10.1210/jc.2011-2576 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22312089  }} </ref>
:*Biphasic [[hypothyroidism]]: 43 % patients of PPT develops symptoms of [[hypothyroidism]] followed recovery .<ref name="pmid22312089">{{cite journal| author=Stagnaro-Green A| title=Approach to the patient with postpartum thyroiditis. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 2 | pages= 334-42 | pmid=22312089 | doi=10.1210/jc.2011-2576 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22312089  }} </ref>  
:*'''Biphasic [[hypothyroidism]]''': 43 % patients of [[Postpartum thyroiditis|PPT]] develop symptoms of [[hypothyroidism]] followed by recovery.<ref name="pmid22312089">{{cite journal| author=Stagnaro-Green A| title=Approach to the patient with postpartum thyroiditis. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 2 | pages= 334-42 | pmid=22312089 | doi=10.1210/jc.2011-2576 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22312089  }} </ref>  
*If left untreated, 25-30% of patients with PPT may progress to develop [[hypothyroidism]]<ref name="pmid10634366">{{cite journal| author=Premawardhana LD, Parkes AB, Ammari F, John R, Darke C, Adams H et al.| title=Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. | journal=J Clin Endocrinol Metab | year= 2000 | volume= 85 | issue= 1 | pages= 71-5 | pmid=10634366 | doi=10.1210/jcem.85.1.6227 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10634366  }} </ref>
*If left untreated, 25-30% of patients with [[Postpartum thyroiditis|PPT]] may progress to develop [[hypothyroidism]].<ref name="pmid10634366">{{cite journal| author=Premawardhana LD, Parkes AB, Ammari F, John R, Darke C, Adams H et al.| title=Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. | journal=J Clin Endocrinol Metab | year= 2000 | volume= 85 | issue= 1 | pages= 71-5 | pmid=10634366 | doi=10.1210/jcem.85.1.6227 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10634366  }} </ref>
*Patients who are anti-TPO antibodies positive,HLA-DRW9 and/or HLA-DRB51 <ref name="pmid3162458">{{cite journal| author=Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K| title=Long term follow-up and HLA association in patients with postpartum hypothyroidism. | journal=J Clin Endocrinol Metab | year= 1988 | volume= 66 | issue= 3 | pages= 480-4 | pmid=3162458 | doi=10.1210/jcem-66-3-480 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3162458  }} </ref> , and developed hypothyroid phase of PPT, are at increased risk of developing permanent  [[hypothyroidism]].<ref name="StuckeyKent2010">{{cite journal|last1=Stuckey|first1=B G A|last2=Kent|first2=G N|last3=Ward|first3=L C|last4=Brown|first4=S J|last5=Walsh|first5=J P|title=ORIGINAL ARTICLE: Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction|journal=Clinical Endocrinology|volume=73|issue=3|year=2010|pages=389–395|issn=03000664|doi=10.1111/j.1365-2265.2010.03797.x}}</ref>
*Patients who are positive for anti-TPO [[antibodies]], HLA-DRW9 and/or HLA-DRB51, and developed [[Hypothyroidism|hypothyroid]] phase of [[Postpartum thyroiditis|PPT]], are at increased risk of developing permanent  [[hypothyroidism]].<ref name="pmid3162458">{{cite journal| author=Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K| title=Long term follow-up and HLA association in patients with postpartum hypothyroidism. | journal=J Clin Endocrinol Metab | year= 1988 | volume= 66 | issue= 3 | pages= 480-4 | pmid=3162458 | doi=10.1210/jcem-66-3-480 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3162458  }} </ref><ref name="StuckeyKent2010">{{cite journal|last1=Stuckey|first1=B G A|last2=Kent|first2=G N|last3=Ward|first3=L C|last4=Brown|first4=S J|last5=Walsh|first5=J P|title=ORIGINAL ARTICLE: Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction|journal=Clinical Endocrinology|volume=73|issue=3|year=2010|pages=389–395|issn=03000664|doi=10.1111/j.1365-2265.2010.03797.x}}</ref>


===Complications===
===Complications===
*Common complications of include:
*Common complications of postpartum thyroiditis include:
**Hypothyroidism<ref name="pmid108745383">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538  }}</ref>
**[[Hypothyroidism]]<ref name="pmid108745383">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538  }}</ref>
**Postpartum depression<ref name="pmid108745382">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538  }}</ref>
**[[Postnatal depression|Postpartum depression]]<ref name="pmid108745382">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538  }}</ref>
**Recurrence <ref name="pmid7062963">{{cite journal| author=Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I et al.| title=High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. | journal=N Engl J Med | year= 1982 | volume= 306 | issue= 14 | pages= 849-52 | pmid=7062963 | doi=10.1056/NEJM198204083061405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7062963  }} </ref>
**Recurrence<ref name="pmid7062963">{{cite journal| author=Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I et al.| title=High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. | journal=N Engl J Med | year= 1982 | volume= 306 | issue= 14 | pages= 849-52 | pmid=7062963 | doi=10.1056/NEJM198204083061405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7062963  }} </ref>
**Fetal mental retardation in future pregnancies in diagnosed cases.<ref name="pmid3394739">{{cite journal| author=Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC| title=The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. | journal=Am J Obstet Gynecol | year= 1988 | volume= 159 | issue= 1 | pages= 203-9 | pmid=3394739 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3394739  }} </ref>
**Fetal [[mental retardation]]<ref name="pmid3394739">{{cite journal| author=Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC| title=The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. | journal=Am J Obstet Gynecol | year= 1988 | volume= 159 | issue= 1 | pages= 203-9 | pmid=3394739 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3394739  }} </ref>
**Overt hyperthyroid symptoms in future pregnancies.<ref name="pmid7062963">{{cite journal| author=Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I et al.| title=High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. | journal=N Engl J Med | year= 1982 | volume= 306 | issue= 14 | pages= 849-52 | pmid=7062963 | doi=10.1056/NEJM198204083061405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7062963  }} </ref>
**Future pregnancies may present with features of overt [[Hyperthyroidism|hyperthyroidism]]<ref name="pmid7062963">{{cite journal| author=Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I et al.| title=High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. | journal=N Engl J Med | year= 1982 | volume= 306 | issue= 14 | pages= 849-52 | pmid=7062963 | doi=10.1056/NEJM198204083061405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7062963  }} </ref>


===Prognosis===
===Prognosis===
* Prognosis is generally good and 90% of patient recover to normal state after 12 months of postpartum.<ref name="pmid27981252">{{cite journal| author=Alemu A, Terefe B, Abebe M, Biadgo B| title=Thyroid hormone dysfunction during pregnancy: A review. | journal=Int J Reprod Biomed (Yazd) | year= 2016 | volume= 14 | issue= 11 | pages= 677-686 | pmid=27981252 | doi= | pmc=5153572 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27981252  }}</ref>
* [[Prognosis]] is generally good and 90% of patient with PPT recover to normal state after postpartum period.<ref name="pmid27981252">{{cite journal| author=Alemu A, Terefe B, Abebe M, Biadgo B| title=Thyroid hormone dysfunction during pregnancy: A review. | journal=Int J Reprod Biomed (Yazd) | year= 2016 | volume= 14 | issue= 11 | pages= 677-686 | pmid=27981252 | doi= | pmc=5153572 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27981252  }}</ref>
* 25-30% in 3.5 to 8.7-year patients with postpartum thyroiditis develop hypothyroidism.
* If left untreated, 25 to 30% patients develop [[hypothyroidism]], 3.5 to 8.7-years after developing [[postpartum thyroiditis]] [[Postpartum thyroiditis|(PPT)]].<ref name="pmid10634366" />


==References==
==References==

Latest revision as of 16:49, 10 November 2017

Postpartum thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Postpartum Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Postpartum thyroiditis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Postpartum thyroiditis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Postpartum thyroiditis natural history, complications and prognosis

CDC on Postpartum thyroiditis natural history, complications and prognosis

Postpartum thyroiditis natural history, complications and prognosis in the news

Blogs on Postpartum thyroiditis natural history, complications and prognosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Postpartum thyroiditis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

Overview

Prognosis for postpartum thyroiditis is generally good. If left untreated, 25 to 30% patients develop hypothyroidism, 3.5 to 8.7-years after developing postpartum thyroiditis (PPT). The symptoms of postpartum thyroiditis usually develop in the twelve months after delivery, abortion or miscarriage of fetus. The symptoms of PPT depend on its clinical course such as classic triphasic, biphasic hyerthyroidism, or biphasic hypothyroidism. Common complications of PPT include hypothyroidism, postpartum depression, and fetal mental retardation. The mother may develop overt hyperthyroid symptoms in future pregnancies. Prognosis of PPT is generally good and 90% of patient recover to normal state after postpartum period.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

References

  1. ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
  2. ↑ 2.0 2.1 2.2 Stagnaro-Green A (2012). "Approach to the patient with postpartum thyroiditis". J Clin Endocrinol Metab. 97 (2): 334–42. doi:10.1210/jc.2011-2576. PMID 22312089.
  3. ↑ 3.0 3.1 Premawardhana LD, Parkes AB, Ammari F, John R, Darke C, Adams H; et al. (2000). "Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity". J Clin Endocrinol Metab. 85 (1): 71–5. doi:10.1210/jcem.85.1.6227. PMID 10634366.
  4. ↑ Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K (1988). "Long term follow-up and HLA association in patients with postpartum hypothyroidism". J Clin Endocrinol Metab. 66 (3): 480–4. doi:10.1210/jcem-66-3-480. PMID 3162458.
  5. ↑ Stuckey, B G A; Kent, G N; Ward, L C; Brown, S J; Walsh, J P (2010). "ORIGINAL ARTICLE: Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction". Clinical Endocrinology. 73 (3): 389–395. doi:10.1111/j.1365-2265.2010.03797.x. ISSN 0300-0664.
  6. ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
  7. ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
  8. ↑ 8.0 8.1 Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I; et al. (1982). "High prevalence of transient post-partum thyrotoxicosis and hypothyroidism". N Engl J Med. 306 (14): 849–52. doi:10.1056/NEJM198204083061405. PMID 7062963.
  9. ↑ Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988). "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction". Am J Obstet Gynecol. 159 (1): 203–9. PMID 3394739.
  10. ↑ Alemu A, Terefe B, Abebe M, Biadgo B (2016). "Thyroid hormone dysfunction during pregnancy: A review". Int J Reprod Biomed (Yazd). 14 (11): 677–686. PMC 5153572. PMID 27981252.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Postpartum_thyroiditis_natural_history,_complications_and_prognosis&oldid=1387335"